Raquel Buj
Raquel Buj
UPMC Hillman Cancer Center and the Department of Pharmacology and Chemical Biology of the University
Correu electrònic verificat a upmc.edu
Citada per
Citada per
DNA methylation profiling of well‐differentiated thyroid cancer uncovers markers of recurrence free survival
V Mancikova, R Buj, E Castelblanco, L Inglada‐Pérez, A Diez, ...
International journal of cancer 135 (3), 598-610, 2014
Deoxyribonucleotide triphosphate metabolism in cancer and metabolic disease
R Buj, KM Aird
Frontiers in endocrinology 9, 177, 2018
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
J Huertas-Martínez, F Court, S Rello-Varona, D Herrero-Martin, ...
Cancer letters 386, 196-207, 2017
Molecular profiling for acromegaly treatment: a validation study
M Puig-Domingo, J Gil, M Sampedro-Nuñez, M Jordà, SM Webb, G Serra, ...
Endocrine-related cancer 27 (6), 375-389, 2020
Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming
R Buj, CW Chen, ES Dahl, KE Leon, R Kuskovsky, N Maglakelidze, ...
Cell reports 28 (8), 1971-1980. e8, 2019
Increased global DNA hypomethylation in distant metastatic and dedifferentiated thyroid cancer
EN Klein Hesselink, C Zafon, N Villalmanzo, C Iglesias, BM van Hemel, ...
The Journal of Clinical Endocrinology & Metabolism 103 (2), 397-406, 2018
Quantification of unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples
R Buj, I Mallona, A Díez-Villanueva, V Barrera, D Mauricio, ...
Oncotarget 7 (9), 10536, 2016
A plasmid toolkit for cloning chimeric cDNAs encoding customized fusion proteins into any Gateway destination expression vector
R Buj, N Iglesias, AM Planas, T Santalucía
BMC molecular biology 14 (1), 1-17, 2013
Simultaneous isotope dilution quantification and metabolic tracing of deoxyribonucleotides by liquid chromatography high resolution mass spectrometry
R Kuskovsky, R Buj, P Xu, S Hofbauer, MT Doan, H Jiang, A Bostwick, ...
Analytical biochemistry 568, 65-72, 2019
Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic implications
R Buj, I Mallona, A Díez-Villanueva, C Zafon, JL Mate, M Roca, ...
Thyroid 28 (5), 601-612, 2018
Targeting IDH1 as a prosenescent therapy in high-grade serous ovarian cancer
ES Dahl, R Buj, KE Leon, JM Newell, Y Imamura, BG Bitler, NW Snyder, ...
Molecular Cancer Research 17 (8), 1710-1720, 2019
Suppression of p16 alleviates the senescence-associated secretory phenotype
R Buj, KE Leon, MA Anguelov, KM Aird
Aging (Albany NY) 13 (3), 3290, 2021
p16: cycling off the beaten path
R Buj, KM Aird
Molecular & cellular oncology 6 (6), e1677140, 2019
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
KE Leon, R Buj, E Lesko, ES Dahl, CW Chen, NK Tangudu, ...
Journal of Cell Biology 220 (8), e202008101, 2021
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH producing adenomas
J Gil, M Marqués‐Pamies, M Jordà, C Fajardo‐Montañana, ...
Clinical Endocrinology, 2020
Loss of p16: A Bouncer of the Immunological Surveillance?
KE Leon, NK Tangudu, KM Aird, R Buj
Life 11 (4), 309, 2021
ATM inhibition drives metabolic adaptation via induction of macropinocytosis
CW Chen, R Buj, ES Dahl, KE Leon, EL Varner, E von Krusenstiern, ...
bioRxiv, 2020
Suppression of p16 increases nucleotide synthesis via mTORC1
R Buj, CW Chen, ES Dahl, KE Leon, R Kuskovsky, N Maglakelidze, ...
BioRxiv, 393876, 2018
Overexpression of oncogenic H-Ras in hTERT-immortalized and SV40-transformed human cells targets replicative and specialized DNA polymerases for depletion
W Tsao, R Buj, KM Aird, JM Sidorova, KA Eckert
PloS one 16 (5), e0251188, 2021
ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells
CW Chen, R Buj, ES Dahl, KE Leon, KM Aird
Heliyon 6 (9), e05097, 2020
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20